LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 55.48 | 84.90 | 6452 | 6567 | 0.9824 | 0.9943 | MN20160318_Q02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 57.18 | 84.90 | 6076 | 6963 | 0.8726 | 0.9576 | MN20160318_Q02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 57.18 | 84.90 | 6128 | 6963 | 0.8800 | 0.9602 | MN20160318_Q02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 57.18 | 84.90 | 6885 | 6963 | 0.9888 | 0.9964 | MN20160318_Q02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 57.18 | 84.90 | 6972 | 6963 | 1.0012 | 1.0004 | MN20160318_Q02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 57.18 | 84.90 | 629 | 6963 | 0.0903 | 0.3703 | MN20160318_Q02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 57.18 | 84.90 | 6363 | 6963 | 0.9138 | 0.9718 | MN20160318_Q02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 57.18 | 84.90 | 506 | 6963 | 0.0727 | 0.3242 | MN20160318_Q02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 57.18 | 84.90 | 6859 | 6963 | 0.9850 | 0.9953 | MN20160318_Q02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 58.88 | 84.90 | 6334 | 7291 | 0.8686 | 0.9566 | MN20160318_Q02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 58.88 | 84.90 | 6395 | 7291 | 0.8770 | 0.9596 | MN20160318_Q02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 58.88 | 84.90 | 7128 | 7291 | 0.9775 | 0.9929 | MN20160318_Q02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 58.88 | 84.90 | 7222 | 7291 | 0.9904 | 0.9970 | MN20160318_Q02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 58.88 | 84.90 | 715 | 7291 | 0.0981 | 0.3933 | MN20160318_Q02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 58.88 | 84.90 | 6677 | 7291 | 0.9157 | 0.9728 | MN20160318_Q02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 58.88 | 84.90 | 558 | 7291 | 0.0765 | 0.3406 | MN20160318_Q02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 58.88 | 84.90 | 7148 | 7291 | 0.9803 | 0.9938 | MN20160318_Q02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 60.59 | 84.90 | 6479 | 7641 | 0.8478 | 0.9498 | MN20160318_Q02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 60.59 | 84.90 | 6538 | 7641 | 0.8555 | 0.9525 | MN20160318_Q02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 60.59 | 84.90 | 7409 | 7641 | 0.9695 | 0.9905 | MN20160318_Q02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 60.59 | 84.90 | 7534 | 7641 | 0.9859 | 0.9956 | MN20160318_Q02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 60.59 | 84.90 | 722 | 7641 | 0.0945 | 0.3906 | MN20160318_Q02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 60.59 | 84.90 | 7065 | 7641 | 0.9245 | 0.9760 | MN20160318_Q02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 60.59 | 84.90 | 564 | 7641 | 0.0738 | 0.3387 | MN20160318_Q02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 60.59 | 84.90 | 7614 | 7641 | 0.9963 | 0.9989 | MN20160318_Q02 | H15 |